Targeting type I PRMTs as promising targets for the treatment of pulmonary disorders: Asthma, COPD, lung cancer, PF, and PH

S Zhou, Q Zhang, H Yang, Y Zhu, X Hu, G Wan, L Yu - Life Sciences, 2024 - Elsevier
Pulmonary disorders, including asthma, chronic obstructive pulmonary disease (COPD),
pulmonary fibrosis (PF), pulmonary hypertension (PH), and lung cancer, seriously impair the …
相关文章

Targeting type I PRMTs as promising targets for the treatment of pulmonary disorders: Asthma, COPD, lung cancer, PF, and PH

S Zhou, Q Zhang, H Yang, Y Zhu, X Hu, G Wan… - Life … - pubmed.ncbi.nlm.nih.gov
Pulmonary disorders, including asthma, chronic obstructive pulmonary disease (COPD),
pulmonary fibrosis (PF), pulmonary hypertension (PH), and lung cancer, seriously impair the …

Targeting type I PRMTs as promising targets for the treatment of pulmonary disorders: Asthma, COPD, lung cancer, PF, and PH.

S Zhou, Q Zhang, H Yang, Y Zhu, X Hu, G Wan, L Yu - Life Sciences, 2024 - europepmc.org
Pulmonary disorders, including asthma, chronic obstructive pulmonary disease (COPD),
pulmonary fibrosis (PF), pulmonary hypertension (PH), and lung cancer, seriously impair the …